Skip to content
Jascap.org
Jeet Association for Support to Cancer Patients
ABOUT
QUICK INFO
स्तन कैंसर
BOOKS
English Books
हिंदी किताबें (Hindi)
मराठी पुस्तके (Marathi)
ગુજરાતી પુસ્તકો (Gujarati)
বাংলা পুস্তিকা (Bengali)
ಕನ್ನಡ ಪುಸ್ತಕಗಳು (Kannada)
తెలుగు పుస్తకాలు (Telugu)
தமிழ் புத்தகங்கள் (Tamil)
മലയാള പുസ്തകങ്ങൾ (Malayalam)
ଓଡିଆ ପୁସ୍ତକ | (Odiya Books)
অসমীয়া (Assamese)
Other sources
FACT SHEETS
English Factsheets
हिंदी तथ्यपत्रिकाएँ (Hindi)
मराठी तत्थपत्रके (Marathi)
ગુજરાતી તથ્ય પત્રકો (Gujarati)
বাংলা ফ্যাক্টশিট (Bengali)
ಕನ್ನಡ ಫ್ಯಾಕ್ಟ್ಶೀಟ್ಗಳು (Kannada)
తెలుగు ఫాక్ట్షీట్లు (Telugu)
Other sources
BLOG
VIDEOS
CONTACT
EVENTS
USEFUL LINKS
PALLIATIVE CARE CENTRES IN INDIA
Donate
ABOUT
QUICK INFO
स्तन कैंसर
BOOKS
English Books
हिंदी किताबें (Hindi)
मराठी पुस्तके (Marathi)
ગુજરાતી પુસ્તકો (Gujarati)
বাংলা পুস্তিকা (Bengali)
ಕನ್ನಡ ಪುಸ್ತಕಗಳು (Kannada)
తెలుగు పుస్తకాలు (Telugu)
தமிழ் புத்தகங்கள் (Tamil)
മലയാള പുസ്തകങ്ങൾ (Malayalam)
ଓଡିଆ ପୁସ୍ତକ | (Odiya Books)
অসমীয়া (Assamese)
Other sources
FACT SHEETS
English Factsheets
हिंदी तथ्यपत्रिकाएँ (Hindi)
मराठी तत्थपत्रके (Marathi)
ગુજરાતી તથ્ય પત્રકો (Gujarati)
বাংলা ফ্যাক্টশিট (Bengali)
ಕನ್ನಡ ಫ್ಯಾಕ್ಟ್ಶೀಟ್ಗಳು (Kannada)
తెలుగు ఫాక్ట్షీట్లు (Telugu)
Other sources
BLOG
VIDEOS
CONTACT
EVENTS
USEFUL LINKS
PALLIATIVE CARE CENTRES IN INDIA
General Information About Cancer
Cancer Test and Screening
Fact Sheets:
E – SCR 001 – Bowel cancer screening
E – SCR 002 – Breast screening
E – SCR 003 – Cervical screening
E – SCR 004 – Family history of breast and – or ovarian cancer
E – SCR 005 – Tests and screening
Types Of Cancer
Breast Cancer
Fact Sheets:
E – 07.01 – HER2 positive breast cancer
E – 07.02 – Inflammatory breast cancer
E – 07.03 – Lobular carcinoma in situ (LCIS)
E – 07.04 – Paget’s disease of the breast
E – 07.05 – Phyllodes tumour
E – 07.06 – Triple negative breast cancer
E – 07.07 – Tubular breast cancer
E – 07.08 – Menopausal symptoms
E – 07.09 – Understanding risk-reducing breast surgery
E – 07.10 – Breast calcifications
Digestive – Gastrointestinal Cancer
Fact Sheets:
E – 13.01 – Small bowel cancer
E – 13.03 – Anorectal melanoma
E – 13.04 – Pseudomyxoma peritonei (PMP)
E – 18.01 – Bile duct cancer (cholangiocarcinoma)
E – 25.01 – Barrett’s oesophagus
E – 25.02 – Making swallowing easier
E – 25.31 – Gastro oesophageal junction cancer
Endocrine – Neuroendocrine
Fact Sheets:
E – 27.01 – Neuroendocrine tumours (NETs)
E – 33A – An overview of endocrine tumours
E – 33A.01 – Tumours of the adrenal glands
E – 33A.02 – Multiple endocrine neoplasia 1 (MEN1)
E – 33A.03 – Multiple endocrine neoplasia 2 (MEN2)
E – 33A.04 – Cancer of the parathyroid glands
E – 33A.05 – Pituitary gland tumours
E – 33B – Thymus gland cancer
Genitourinary
Fact Sheets:
E – 16.01 – Cancer of the ureter and renal pelvis
E – 28.01 – Prostate cancer and hormonal symptoms
Head and Neck Cancers
Fact Sheets:
E – 17.01 – Tracheal cancer (cancer of the windpipe)
E – 22.02 – Nasopharyngeal cancer (cancer of the nasopharynx)
E – 22.03 – Oropharyngeal cancer (cancer of the oropharynx)
E – 22.04 – Nasal and sinus cancers
E – 76A – Eye cancer (Ocular melanoma)
E – 117.01 – Cancer of the ea
r
Hematology - Leukaemias
Fact Sheets:
E – 01.01 – T cell Acute Lymphoblastic Leukaemia
E – 11.01 – Transformation of CLL (Richter’s Syndrome and Prolymphocytic transformation)
E – 11.02 – Large granular lymphocytic leukaemia
E – 91.01 – Hairy cell leukaemia
Hematology - Lymphomas
Fact Sheets:
E –
24.00 – Types of non-Hodgkin lymphoma
E – 24.01(T) – Anaplastic large cell lymphoma
E – 24.02(B) – Burkitt lymphoma
E – 24.03(T) – Cutaneous T-cell lymphoma
E – 24.04(B) – Diffuse large B-cell lymphoma
E – 24.05(B) – Follicular lymphoma
E – 24.06(B) – Splenic marginal zone lymphoma
E – 24.07(T) – Lymphoblastic lymphoma
E – 24.08(B) – MALT lymphoma
E – 24.09(B) – Mantle cell lymphoma
E – 24.10(B) – Primary mediastinal large B-cell lymphoma
E – 24.11(B) – Nodal marginal zone B-cell lymphoma
E – 24.12(T) – Peripheral T-cell lymphoma (NOS)
E – 24.13(B) – Small lymphocytic lymphoma
E – 24.14(T) – Angioimmunoblastic T-cell lymphoma
E – 24.15(B) – Waldenstrom’s macro globulin aemia
Hematology - Myeloma
Fact sheets:
E – 23.01 – Plasma cell leukaemia
E – 23.02 – Solitary plasmacytoma
E – 23.03 – MGUS (monoclonal gammopathy of unknown significance)
Hematology - Other Blood Disorders
Fact Sheets:
E – 70.02 – Down syndrome and leukaemia
E – 70.03 – Chronic myelomonocytic leukaemia (CMML)
Musculoskeletal
Fact Sheets:
E – 04.01 – Chondrosarcoma
E – 04.02 – Chordoma
E – 04.03 – Ewing Sarcoma of the bone
E – 04.04 – Osteosarcoma
E – 30.01 – Gastrointestinal stromal tumours (GISTs)
E – 30.02 – Leiomyosarcoma
E – 30.03 – Rhabdomyosarcoma
Neurologial – CNS Cancers
Fact Sheets:
E – 06.01 – Acoustic Neuroma
E – 06.02 – Astrocytomas
E – 06.03 – Primary CNS lymphoma
E – 06.04 – Ependymoma
E – 06.05 – Haemangioblastoma
E – 06.06 – Medulloblastoma
E – 06.07 – Meningioma
E – 06.08 – Mixed gliomas
E – 06.09 – Oligodendroglioma
E – 06.10 – Pineal region tumours
E – 06.11 – Pituitary gland tumours
E – 06.12 – Secondary brain cancer
E – 06.13 – Spinal cord tumours
Skin Cancer
Fact Sheets:
E – 29.01 – Bowen’s disease
Women – Gyenecological
Fact Sheets:
E – 10A – Cervical intra-epithelial neoplasia (CIN)
E – 10B – HPV and cancer
E – 22.04 – Nasal and sinus cancer
E – 26.01 – Fallopian tube cancer
E – 26.02 – Germ cell ovarian cancer
E – 26B – Primary peritoneal cancer (PPC)
E – 35.01 – Vulval intra-epithelial neoplasia (VIN)
E – 35.02 – Vulval lichen sclerosus and lichen planus
E – 38.03 – Prophylactic cranial radiotherapy (PCR)
E -75A – Vaginal intra-epithelial neoplasia (VAIN)
CHILDREN CANCER
Children Cancer
Fact Sheets:
E – 61.01 -Acute lymphoblastic leukaemia (ALL) in children
E – 61.02 -Acute myeloid leukaemia (AML) in children
E – 61.03 – Brain tumours in children
E – 61.04 -Ewing sarcoma in children
E – 61.05 -Germ cell tumours in children
E – 61.06 -Hodgkin lymphoma in children
E – 61.07 -Langerhans cell histiocytosis (LCH) in children
E – 61.08 -Liver tumours in children
E – 61.09 -Neuroblastoma in children
E – 61.10 -Non-Hodgkin lymphoma (NHL) in children
E – 61.11 -Osteosarcoma in children
E – 61.12 -Rare tumours in children
E – 61.13 -Retinoblastoma in children
E – 61.14 -Rhabdomyosarcoma in children
E – 61.15 -Wilms’ tumour in children
CANCER Treatments
Biological or Targeted Therapies
Fact Sheets:
E – BT000 – Targeted therapies
E – BT001 – Alemtuzumab
E – BT001a – Abemaciclib (Verzenios®)
E – BT001b – Afatanib (Giotrif®)
E – BT002 – Aldesleukin (Proleukin®)
E – BT002a – Axitinib (Inlyta®)
E – BT003 – Bevacizumab (Avastin®)
E – BT004 – Bortezomib (Velcade®)
E – BT005 -Bosutinib
E – BT005a – Brentuximab vedotin (Adcetris®)
E – BT006 – Cabozantinib (Cometriq®, Cabometyx®)
E – BT006a – Carfilzomib (Kyprolis®)
E – BT007 – Ceritinib (Zykadia® )
E – BT008 – Cetuximab (Erbitux®)
E – BT008a – Crizotinib (Xalkori®)
E – BT009 – Dabrafenib and trametinib
E – BT009a – Daratumumab (Darzalex®)
E – BT010 – Dasatinib (Sprycel®)
E – BT011 – Denosumab (Xgeva®, Prolia®)
E – BT012 – Erlotinib (Tarceva®)
E – BT012a – Encorafenib (Braftovi®) and binimetinib
(Mekt
ovi®)
E – BT013 – Erythropoietin
E – BT014 – Everolimus (Afinitor®)
E – BT015 – Gefitinib (Iressa®)
E – BT016 – Gemtuzumab ozogamicin (Mylotarg®)
E – BT016a – Gilteritinib (Xospata®)
E – BT017 – Ibrutinib (Imbruvica®)
E – BT017a – Idelalisib (Zydelig®)
E – BT017b – Imatinib
E – BT018 – Lenalidomide (Revlimid®)
E – BT019 – Lenvatinib (Lenvima®, Kisplyx®)
E – BT019a – Midostaurin
E – BT020 – Nilotinib (Tasigna®)
E – BT021 – Nintedanib (Vargatef®)
E – BT021a – Niraparib (Zejula®)
E – BT022 – Obinutuzumab (Gazyvaro®)
E – BT023 – Olaparib (Lynparza®)
E – BT023a – Osimertinib (Tagrisso®)
E – BT024 – Palbociclib (Ibrance®)
E – BT025 – Panitumumab (Vectibix®)
E – BT026 – Pazopanib
E – BT027 – Pembrolizumab
E – BT028 – Pertuzumab, trastuzumab and docetaxel
E – BT029 – Pomalidomide (Imnovid®)
E – BT030 – Ponatinib (Iclusig®)
E – BT031 – Ribociclib (Kisqali®)
E – BT032 – Rituximab
E – BT032a – Ruxolitinib (Jakavi®)
E – BT033 – Sorafenib (Nexavar®)
E – BT034 – Sunitinib (Sutent®)
E – BT035 – Trastuzumab emtansine (Kadcyla®)
E – BT035a – Tivozanib (Fotivda®)
E – BT035b – Trastuzumab and pertuzumab
E – BT036 – Venetoclax (Venclyxto®)
Chemotherapy
Fact Sheets:
E – 37.01 – Central lines
E – 37.02 – Implantable Ports
E – 37.03 – PICC Lines
E – 37.04 – Intrathecal Chemotherapy
E – 37.05 – Chemotherapy into a limb
E – 37.06 – Cannulas
Combination Chemotherapy Regimen
Fact Sheets:
E – CCR 001 – ABCP
E – CCR 002 – ABVD
E – CCR 003 – AC
E – CCR 004 – BEACOPP
E – CCR 005 – BEAM chemotherapy
E – CCR 006 – BEP
E – CCR 007 – Carboplatin and etoposide
E – CCR 007a – Carboplatin and fluorouracil (5FU)
E – CCR 008 – Carboplatin and liposomal doxorubicin
E – CCR 009 – CAV (VAC)
E – CCR 010 – ChIVPP
E – CCR 011 – CHOP
E – CCR 012 – Cisplatin and 5FU
E – CCR 013 – Cisplatin and topotecan
E – CCR 014 – CMF
E – CCR 015 – CODOX-M
E – CCR 016 – CTD
E – CCR 017 – CVP
E – CCR 018 – De Gramont and modified de Gramont chemotherapy
E – CCR 018a – Dabrafenib and trametinib
E – CCR 019 – DHAP
E – CCR 020 – Docetaxel (Taxotere®) and carboplatin chemotherapy
E – CCR 021 – Docetaxel (Taxotere®) and cisplatin
E – CCR 022 – Doxorubicin and ifosfamide
E – CCR 023 – EC
E – CCR 024 – ECF
E – CCR 025 – ECX
E – CCR 026 – EOX
E – CCR 027 – ESHAP chemotherapy
E – CCR 028 – Etoposide and cisplatin chemotherapy (EP)
E – CCR 029 – FCR
E – CCR 030 – FEC chemotherapy
E – CCR 031 – FEC-T
E – CCR 032 – FLAG-Ida
E – CCR 033 – FLOT
E – CCR 034 – FOLFIRINOX (FOLFOXIRI)
E – CCR 035 – FOLFOX
E – CCR 036 – GemCap
E – CCR 037 – GemCarbo chemotherapy
E – CCR 038 – GemCis chemotherapy
E – CCR 038a – Gemcitabine and nab-paclitaxel (Abraxane®)
E – CCR 039 – HCX
E – CCR 040 – Hyper-CVAD
E – CCR 041 – ICE chemotherapy
E – CCR 042 – Irinotecan with 5FU and folinic acid
E – CCR 043 – IVAC
E – CCR 044 – MPT
E – CCR 044a – MATRIX
E – CCR 044b – Mitomycin and fluorouracil (5FU) with radiotherapy
E – CCR 045 – MVAC
E – CCR 046 – Paclitaxel and carboplatin
E – CCR 047 – Pemetrexed and carboplatin
E – CCR 048 – Pemetrexed and cisplatin
E – CCR 049 – Pertuzumab, trastuzumab and docetaxel
E – CCR 050 – PMitCEBO
E – CCR 050a – Pola-BR
E – CCR 051 – R-CHOP
E – CCR 052 – R-CVP
E – CCR 053 – R-DHAP
E – CCR 054 – R-ICE chemotherapy
E – CCR 055 – TAC chemotherapy
E – CCR 056 – TC
E – CCR 057 – TIP
E – CCR 058 – Trifluridine-tipiracil hydrochloride (Lonsurf®)
E – CCR 059 – Vinorelbine and carboplatin
E – CCR 059a – Vinorelbine and cisplatin (VP)
E – CCR 060 – XELOX (or CAPOX)
Individual chemotherapy drugs
Fact Sheets:
E – C001 – Amsacrine (Amsidine®)
E – C002 – Asparaginase
E – C003 – Azacitidine
E – C004 – Bendamustine
E – C005 – Bleomycin
E – C006 – Busulfan
E – C007 – Cabazitaxel
E – C008 – Capecitabine
E – C009 – Carboplatin
E – C010 – Carmustine
E – C011 – Chlorambucil
E – C012 – Cisplatin
E – C013 – Cladribine (Leustat® or LITAK®)
E – C014 – Clofarabine (Evoltra®)
E – C015 – Cyclophosphamide
E – C016 – Cytarabine
E – C017 – Dacarbazine (DTIC)
E – C018 – Dactinomycin (Cosmegen Lyovac®)
E – C019 – Daunorubicin
E – C020 – Docetaxel
E – C021 – Doxorubicin
E – C022 – Epirubicin
E – C023 – Eribulin (Halaven®)
E – C024 – Etoposide
E – C025 – Fludarabine
E – C026 – Fluorouracil (5FU)
E – C027 – Gemcitabine
E – C028 – Gliadel® wafers
E – C029 – Hydroxycarbamide
E – C030 – Idarubicin
E – C031 – Ifosfamide
E – C032 – Irinotecan (Campto®)
E – C033 – Liposomal doxorubicin
E – C034 – Lomustine
E – C035 – Methotrexate
E – C036 – Mitomycin
E – C037 – Mitotane
E – C038 – Mitoxantrone
E – C039 – Nab-paclitaxel (Abraxane®)
E – C040 – Oxaliplatin
E – C041 – Paclitaxel
E – C042 – Pemetrexed
E – C043 – Pentostatin (Nipent®)
E – C044 – Procarbazine
E – C045 – Raltitrexed (Tomudex®)
E – C046 – Streptozocin
E – C047 – Temozolomide
E – C048 – Thiotepa
E – C049 – Tioguanine
E – C050 – Topotecan
E – C051 – Trabectedin
E – C052 – Treosulfan
E – C053 – Vinblastine (Velbe®)
E – C054 – Vincristine (Oncovin®)
E – C055 – Vinorelbine
Hormonal Therapies
Fact Sheets:
E – HT 000 – Hormonal therapies
E – HT 001 – Abiraterone acetate (Zytiga®)
E – HT 002 – Anastrozole (Arimidex®)
E – HT 003 – Bicalutamide
E – HT 004 – Buserelin (Suprefact®)
E – HT 005 – Cyproterone acetate (Cyprostat®)
E – HT 006 – Degarelix
E – HT 007 – Diethylstilbestrol (Stilboestrol®)
E – HT 008 – Enzalutamide
E – HT 009 – Exemestane
E – HT 010 – Flutamide
E – HT 011 – Fulvestrant (Faslodex®)
E – HT 012 – Goserelin for men (Zoladex®, Zoladex LA®)
E – HT 013 – Goserelin for Women (Zoladex®)
E – HT 014 – Letrozole (Femara®)
E – HT 015 – Medroxyprogesterone acetate (Provera®)
E – HT 016 – Tamoxifen
E – HT 017 – Toremifene (Fareston®)
E – HT 018 – Triptorelin (Decapeptyl® or Gonapeptyl®)
Radiotherapy
Fact sheets:
E – 38.02 – Proton beam therapy
E – 38.03 – Prophylactic cranial radiotherapy (PCR)
E – 38.04 – Selective internal radiation therapy (SIRT)
Supportive and Other Treatments
Supportive Treatments
Fact Sheets:
E – ST 00 – Supportive and other treatments
E – ST 01 – Blood transfusions
E – ST 02 – Erythropoietin
E – ST 03 – G-CSF (Granulocyte-colony stimulating factor)
E – ST 04 – Nephrostomy
E – ST 05 – Plasma exchange
E – ST 06 – Platelet transfusions
E – ST 07 – Steroids
Other Treatments
Fact Sheets:
E – OT 01 – Hyperbaric oxygen (HBO) treatment
E – OT 02 – Photodynamic therapy (PDT)
E – OT 03 – Radiofrequency ablation (RFA)
Bisphosphonates
Fact Sheets:
E – BIS 000 – Bisphosphonates
E – BIS 001 – Clodronate
E – BIS 002 – Ibandronic acid
E – BIS 003 – Pomidronate
E – BIS 004 – Zoledronic acid
Surgery
Fact Sheets:
E – 09.00 – Surgery
E – 09.01 – Amputation
E – 09.02 – Breast-conserving surgery
E – 09.03 – Breast reconstruction
E – 09.04 – Risk-reducing breast surgery
E – 09.05 – Chemoradiation
E – 09.06 – Craniotomy
E – 09.07 – Cystectomy (removing the bladder)
E – 09.08 – Drug treatments to protect your bones
E – 09.09 – Electrochemotherapy
E – 09.10 – Endoscopic resection and transoral laser microsurgery
E – 09.11 – Gastrectomy
E – 09.12 – Hysterectomy
E – 09.13 – Laryngectomy
E – 09.14 – Leukapheresis
E – 09.15 – Liver cancer ablation
E – 09.16 – Oesophagectomy
E – 09.17 – Orchidectomy
E – 09.18 – Pelvic exenteration for men
E – 09.19 – Pelvic exenteration for women
E – 09.20 – Radiolabelled therapies for medullary thyroid cancer
E – 09.21 – Ureteric stent
E – 09.22 – Vaginal reconstruction
IMMUNOTHERAPY
Fact Sheets:
E – IT 000 -Immunotherapy
E – IT 001 – Atezolizumab
E – IT 002 -Blinatumomab
E – IT 003 -Durvalumab
E – IT 004 -Ipilimumab
E – IT 005 -Nivolumab (Opdivo®)
E – 206.00 – Immunotherapy
Living With Cancer
COPING WITH CANCER - Physical Effects
Fact Sheets:
E – 31.01 – Dietary problems after surgery for stomach cancer
E – 41.01 – Scalp cooling
E – 42.01 – Nutritional support or tube feeding
E – 43.01 – Cancer and fertility
E – 48.01 – Cardiopulmonary resuscitation (CPR) for people with cancer
E – 49.01 – Chemotherapy and mouth care
E – 49.02 – Radiotherapy and mouth care
Scroll to top
Area of Interest
Book Stall
Advocacy
Patient Interaction
Translation
Name
Email
Mobile / Phone No.
Work Experience
NGO
Other
Ease on Computer
No Experience
Basic Usage
Proficient
Education Qualification
High School
Graduate
Post Graduate and Above
How much time can you devote per week?
Half Day (Morning to Afternoon)
Half Day (Afternoon to Evening)
Full Day
More than a Day
Get Involved